Dissertation > Excellent graduate degree dissertation topics show

Experimental study on anti VEGF drug bevacizumab on retinal safety

Author: FanCong
Tutor: ZhaoJiaLiang
School: Beijing Union Medical College
Course: Clinical
Keywords: Bevacizumab Vascular Endothelial Growth Factor anti-VEGF neuralretinal toxicity TUNEL
CLC: R774.1
Type: PhD thesis
Year: 2010
Downloads: 28
Quote: 0
Read: Download Dissertation


Background:Vascular endothelial growth factor (VEGF) has been implicated as the key angiogenic stimulus responsible for the formation of ocular neovascularization, especially exudative AMD. Recently, the development of VEGF antagonists introduced a new treatment regimen which has led to better long-term results for ocular neovascularization. Bevacizumab (Avastin; Genentech, South San Francisco, CA) is used off-label in AMD and has shown good effectiveness and tolerability. However, previous research has shown that VEGF exerts neutrophic and neuroprotective effects on nervous system. This may raise the concern that therapeutic inhibition on VEGF for the treatment of neovascular eye diseases may have an adverse impact on the neuroprotective effects of VEGF, thus may cause the injury to neural retinal cells, even though clinical evidence for this theoretical assumption is lacking to date.Objective:To evaluate the effect of Bevacizumab on the neurosensory retinas in culture to approve the safety in clinical use in ophthalmology.Methods:The complex eye tissues of the adult porcine, including retina, choroid and sclera, were cultured for12,24and48hours. Bevacizumab was added to the culture at different concentrations (group A were given no Bevacizumab as controls, group B, C and D were given Bevacizumab at the concentrations of0.125,0.25,1.25mg/ml respectively). After12,24and48hours in culture, the neurosensory retinas were analyzed histologically under light microscope, immunohistochemically for the expression of glial fibrillary acidic protein (GFAP), by TUNEL for apoptosis and by electromicroscopy for the ultrastructure.Results:Histomorphologic observation showed well-preserved nuclear layers with no signs of cellular disorganization, retinal inflammation after exposure to group B and the controls, whereas in group C and D, found the swelling and the loss of retinal ganglion cells (RGCs), and the disorganized photoreceptor layer (PRL). TUNEL system showed no evident increase of apoptosis in each retinal nuclear layer in group B compared to the controls (P>0.05). Group C (24h,48h) and group D (12h,24h) had an evident rise in cell apoptosis in RGC layer (P<0.05), but not in the internal nuclear layer and outer nuclear layer. GFAP expression in Muller cells were detected in group C (48h) and group D (24h,48h), no such signals were observed in other groups and in controls. By electron microscopic observation, the dilation of the rough endoplasmic reticulum(RER) in RGCs, and the decrease even loss of the mitochondrial cristae in the inner segraents of photoreceptors were found in group C and D.Conclusion:No evident signs of retinal toxicity were found histologically, immunohistochemically, by TUNEL testing and by electron microscopy in the concentration of0.125mg/ml, while some certain damage of RGCs and photoreceptor cells were observed in the concentrations of0.25mg/ml and1.25mg/ml, which indicates a lower concentration of Bevacizumab is probably safe to the neurosensory retina, and higher concentration may have an advese effect. Therefore, we should be cautious to the dosage and frequency of Bevacizumab when using in the vitreal injection.

Related Dissertations

  1. The Research on Treatment of Lentivirus-mediated hVEGF-165 Gene Transferring Mesenchymal Stem Cells on Rat Hind Limb Ischemia,R329
  2. BMP2 and VEGF165 Genes Transfected Rat Bone Marrow Mesechymal Stem Cells Simultaneity Expression,R329
  3. Expression of TNF-α, MMP-9 and VEGF in BALF of Rats with Emphysema and Their Mutual Relationship,R563.3
  4. Intravitreal Injection of Bevacizumab Combined Triamcinolone Acetonide for Diabetic Macular Edema,R774.5
  5. Bevacizumab -PLGA Microspheres intravitreal injection in rabbit eyes pharmacokinetics and distribution of drugs,R96
  6. Intravitreal injection of bevacizumab PLGA Microspheres Synthesis and identification of,R943
  7. The Effects of the VEGF Different Genotype Carriers on the Hypoxia Training to Acute Mountain Sickness,G804.2
  8. Dynamic Observation on the Plasma Level of Vascular Endothelial Growth Factor and Matrix Metalloproteinases in Advanced Hepatocellular Carcinoma Patients after Transarterial Chemoembolization Combined with Infusion of Endostar,R735.7
  9. Intravitreal injection of Bevacizumab treatment of idiopathic choroidal neovascularization lesion,R773.4
  10. The Expression and Biological Mechanism of Angiopoeitin 2 in Glomerular Endothelial Cultured in High Glucose Ambient,R587.2
  11. The Epression of Hypoxia-inducible Factor-1 Alpha in Cutaneous Squamous Cell Carcinoma and Its Role in Promoting Cell Proliferation,R739.5
  12. The Effect of IL-17 on VEGF Expression in Human Nsclc Cell in Vitro,R734.2
  13. The Influence of Vascular Endothelial Growth Factor and Steroid Hormone Levels in Follicular Fluids on Oocyte Maturation and Fertilization,R714.8
  14. Research on Strategic Development on Generic Anti Cancer Drugs Bevacizumab and Erlotinib Hydrochloride for Harbin Pharmaceutical Group,F426.72
  15. Expression and Clinical Significance of Ⅱ-24 and VEGF-C in Cervical Sqamous Cell Carcinoma,R737.33
  16. Correlation between Expression of S100A4, Vascular Endothelial Growth Factor C and Lymph Node Metastasis and Prognosis in Gastric Carcinoma,R735.2
  17. APE1 and VEGF Expression and Their Correlation with Prognosis in Non-small Cell Lung Cancer,R734.2
  18. VEGF pretreatment on bone marrow mesenchymal stem cells in the heart rate of retention,R54
  19. Relation between VEGF and Vascular Positive Remodeling after Stent-implantation and the Effect on the Expression of VEGF and MAC by Different Stents,R541.4
  20. Effects of Erzhitiangui Decoction on VEGF During Embryo Implantation of Luteal Phase Defect Women,R285
  21. ~ (18) F-SFB-Annexin B1 probe Experimental evaluation of apoptosis,R817.4

CLC: > Medicine, health > Ophthalmology > Retina and optic nerve diseases > Retinal disease
© 2012 www.DissertationTopic.Net  Mobile